Mobilization of progenitor cells and vessel healing after implantation of SYNERGY in acute coronary syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 08 2021
Historique:
received: 26 02 2021
accepted: 12 08 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 9 11 2021
Statut: epublish

Résumé

This study was aimed to compare the vascular healing process of a SYNERGY stent with that of a PROMUS PREMIER stent in patients with acute coronary syndrome (ACS). In 71 patients with ACS, undergoing coronary stent implantation using the SYNERGY stent (n = 52) or PROMUS PREMIER stent (n = 19), we measured circulating CD34+/CD133+/CD45

Identifiants

pubmed: 34453096
doi: 10.1038/s41598-021-96730-9
pii: 10.1038/s41598-021-96730-9
pmc: PMC8397756
doi:

Substances chimiques

Antigens, CD 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17315

Informations de copyright

© 2021. The Author(s).

Références

Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):408-15
pubmed: 21030714
Lancet. 2018 Jan 6;391(10115):41-50
pubmed: 29102362
Circ J. 2018 Sep 25;82(10):2594-2601
pubmed: 29998921
JAMA Cardiol. 2017 Mar 1;2(3):235-237
pubmed: 28114677
Circulation. 2007 May 8;115(18):2435-41
pubmed: 17438147
Circulation. 2004 Oct 5;110(14):2039-46
pubmed: 15451799
J Am Coll Cardiol. 2012 Apr 10;59(15):1362-70
pubmed: 22341736
Am J Hypertens. 2008 Nov;21(11):1203-9
pubmed: 18787520
Int J Cardiol. 2013 Oct 12;168(5):4617-23
pubmed: 23932862
J Am Coll Cardiol. 2006 May 16;47(10):2112-5
pubmed: 16697332
Circulation. 2007 Aug 21;116(8):910-6
pubmed: 17684153
Circ Cardiovasc Interv. 2015 Apr;8(4):
pubmed: 25855680
JACC Cardiovasc Interv. 2017 Mar 13;10(5):489-499
pubmed: 28279316
JACC Cardiovasc Interv. 2011 Oct;4(10):1057-66
pubmed: 22017929
Circulation. 2007 Feb 6;115(5):553-61
pubmed: 17261663
JACC Cardiovasc Interv. 2009 May;2(5):453-8
pubmed: 19463470
Circ Cardiovasc Interv. 2019 Sep;12(9):e008152
pubmed: 31451014
JACC Cardiovasc Interv. 2009 Jun;2(6):534-41
pubmed: 19539258
Catheter Cardiovasc Interv. 2019 Aug 1;94(2):204-209
pubmed: 30737973
J Vasc Surg. 2002 Nov;36(5):1031-9
pubmed: 12422115
Am J Cardiol. 2009 Dec 15;104(12):1654-9
pubmed: 19962470
PLoS One. 2018 Nov 26;13(11):e0207386
pubmed: 30475845
Int J Cardiol Heart Vasc. 2018 Feb 16;18:17-24
pubmed: 29556525
JACC Cardiovasc Interv. 2009 Nov;2(11):1035-46
pubmed: 19926041
Circulation. 2005 May 3;111(17):2257-73
pubmed: 15867193
PLoS One. 2018 Jan 5;13(1):e0190494
pubmed: 29304136
Int J Cardiovasc Imaging. 2018 Apr;34(4):515-522
pubmed: 29159531

Auteurs

Masashi Sakuma (M)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan. masakuma@dokkyomed.ac.jp.

Setsu Nishino (S)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Takahisa Nasuno (T)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Michiya Kageyama (M)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Michiaki Tokura (M)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Ryoichi Sohma (R)

Advanced Medical Science Research Center, Dokkyo Medical University, Mibu, Tochigi, Japan.

Ken-Ichi Inoue (KI)

Advanced Medical Science Research Center, Dokkyo Medical University, Mibu, Tochigi, Japan.

Tomoaki Kanaya (T)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Syotaro Obi (S)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Shigeru Toyoda (S)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Shichiro Abe (S)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Guiherme F Attizzani (GF)

Division of Cardiovascular Medicine, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Gabriel T R Pereira (GTR)

Division of Cardiovascular Medicine, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Hiram G Bezerra (HG)

Division of Cardiovascular Medicine, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Teruo Inoue (T)

Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH